Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "IDA"

2294 News Found

SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr
News | August 10, 2023

SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr

The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023


Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr
News | August 10, 2023

Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr

Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023


Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr
News | August 10, 2023

Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr

Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023


Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr
News | August 10, 2023

Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr

Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023


IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr
News | August 10, 2023

IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr

IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023


Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr
News | August 10, 2023

Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr

Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023


Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
News | August 09, 2023

Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr

US FDA approval is in line with de-risking strategy for additional API site to service our global customer base


KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr
News | August 08, 2023

KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr

KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023


Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr
News | August 08, 2023

Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023


Gland Pharma posts Q1 FY24 consolidated PAT at Rs. 194.10 Cr
News | August 08, 2023

Gland Pharma posts Q1 FY24 consolidated PAT at Rs. 194.10 Cr

Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023